Get Paid For Watching - Sign Up Now - FREE!
Username:    Password:    
WallSt TV WallSt.net Mywallst WallSt Radio
Home Exclusives News Interviews Podcasts Tools Forums Rookies Shop
Home My Profile Join Browse Search Mail Blogs Forum Rookies Login
Home 3 Minute Press Show News Magazine Analyst's Review Sweet Picks Conference Coverage Login
Home Search Podcasts Submit a Podcast Contact Us Login
Featured Show
This video was published 48 Days 10 Hours 58 Mins ago.

Premium Access: Available NOW
Member Access: Available NOW
Public Access: Available NOW
THE 3 MINUTE PRESS SHOW with Tracee Tolentino
Discover the News behind the News from today's leading executives. Each day we interview the leading Executives on the press of that day.

The 3 Minute Press Show gives you the:
Who, What, Where, When, Why and How of this Press and how it will impact the company and its shareholders.

Members are encouraged to ask these executives questions through their message boards at Mywallst

3 Minute Press Show - Wednesday, July 2, 2008
Loading..
Featured Company:
Alseres Pharmaceuticals, Inc.

Exchange:
NASDAQ

Ticker:
ALSE

Interviewee:
Peter Savas
Chairman & CEO

Back to Full Show
Alseres Pharmaceuticals, Inc. (ALSE)

Alseres Pharmaceuticals, Inc. is engaged in the development of therapeutic and diagnostic products primarily for disorders in the central nervous system (CNS). The Company maintains a world-class intellectual property position in the field of regenerative therapeutics. The Company's energy and focus is reflected in several important initiatives. Cethrin, a recombinant-protein-based drug designed to promote nerve repair after acute spinal cord injury, demonstrated positive interim results in a Phase I/IIa clinical trial. The Company's research and pre-clinical programs include, Inosine for the treatment of spinal cord injury and stroke, Oncomodulin for the treatment of ocular injury and disease and research programs directed at a number of regenerative therapies including bone repair. The Company has a robust molecular imaging development program targeting diagnosis of Parkinson's disease and potentially dementia. The Company's lead molecular imaging product candidate is Altropane which is in Phase III clinical trials for the diagnosis of Parkinsonian Syndromes including Parkinson's Disease. The Company has research collaborations with Harvard Medical School and Children's Hospital Boston.



For more advance tools and analysis, visit the Tools page.

Comments News Level II Profile Financials Insiders Filings


  User Comments

0
Bulls
   0
Bears
     






Be the first to comment on
Alseres Pharmaceuticals, Inc. (NASDAQ: ALSE)





Comment on Alseres Pharmaceuticals, Inc.
Please log in to post a comment.
Username:    Password:  

Don't have an account? 

Featured Companies
Vidshadow, Inc.
Jordan Hudgens
CEO
Monday, June 30, 2008

Founded in 2006 by CEO Jordan Hudgens and based in Orange County, CA, Vidshadow is one of the Internet's fastest growing video distribution networks providing solutions to advertisers, content provide...

Vidshadow, Inc.

Jordan Hudgens
CEO
Monday, May 5, 2008

Founded in 2006 by CEO Jordan Hudgens and based in Orange County, CA, Vidshadow, Inc. is one of the Internet’s fastest growing video distribution networks providing solutions to advertisers, content p...

China YouTV Corporation

Angela Du
Manager of Public Relations
Monday, April 7, 2008

Established in May 2005, and further funded by HuaJu Network in July 2006, CnBoo.com developed from a simple video network site, to become the leader in online video and the premier destination to w...



Latest Episodes
3 Minute Press Show  - 08.19.08
SinoFresh HealthCare, Inc., Seafarer Exploration Corp., FIMA, Inc., CityView Corporation Limited, Exousia Advanced Materials, Inc.
3 Minute Press Show  - 08.18.08
Statmon Technologies Corp.
3 Minute Press Show  - 08.15.08
Bonds.com Group, Inc., Smart Energy Solutions, Inc., SARS Corporation
3 Minute Press Show  - 08.14.08
Heritage Capital Credit Corporation, Seamless Wi-Fi, Inc., LifeVantage Corporation
3 Minute Press Show  - 08.13.08
Natural Nutrition, Inc., Legacy Technology Holdings, Inc., iSECUREtrac Corporation, Universal Detection Technology, Peak Resources, Inc.


HOME | SUPPORT | EDITORIAL | CONFLICT POLICY | TERMS OF USE | CONDITIONS OF USE | PRIVACY POLICY | DISCLAIMER | SERVICES | CONTACT US |

©2008 WallSt TV All Rights Reserved.
The views and ideas expressed in the videos on this site do not necessarily reflect those of WallSt TV or its affiliates.